NeuroPace, Inc.
NPCE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $27 | $24 | $23 | $21 |
| % Growth | 16.3% | 4.4% | 4.9% | – |
| Cost of Goods Sold | $6 | $5 | $5 | $5 |
| Gross Profit | $21 | $18 | $17 | $16 |
| % Margin | 77.4% | 77.1% | 77% | 75.4% |
| R&D Expenses | $7 | $7 | $7 | $6 |
| G&A Expenses | $5 | $6 | $0 | $0 |
| SG&A Expenses | $17 | $18 | $15 | $14 |
| Sales & Mktg Exp. | $13 | $12 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $24 | $25 | $22 | $20 |
| Operating Income | -$3 | -$7 | -$5 | -$4 |
| % Margin | -9.5% | -29% | -22.9% | -17% |
| Other Income/Exp. Net | -$1 | -$2 | -$1 | -$2 |
| Pre-Tax Income | -$3 | -$9 | -$7 | -$5 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$9 | -$7 | -$5 |
| % Margin | -12.8% | -36.8% | -29.3% | -24.5% |
| EPS | -0.11 | -0.26 | -0.21 | -0.18 |
| % Growth | 57.7% | -23.8% | -16.7% | – |
| EPS Diluted | -0.11 | -0.26 | -0.21 | -0.18 |
| Weighted Avg Shares Out | 33 | 33 | 31 | 30 |
| Weighted Avg Shares Out Dil | 33 | 33 | 31 | 30 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $1 | $1 |
| Interest Expense | $1 | $2 | $2 | $2 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$6 | -$4 | -$3 |
| % Margin | -9% | -26% | -17.6% | -12.1% |